Magnetic Resonance Imaging (MRI) Viability: Comparison of Myocardial Viability by Positron Emission Tomography and MRI

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00166179

Enrollment

Registered

2005-09-14

Start date

2003-11-30

Completion date

2006-10-31

Last updated

2014-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

CAD

Brief summary

The purpose of this study is to compare cardiac MRI with positron emission tomography (PET) with fluorodeoxyglucose (FDG) to determine if cardiac MRI images are as good as, or better, than PET with FDG.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 95 Years

Healthy volunteers

Inclusion criteria

* PET-FDG ordered to assess myocardial viability

Exclusion criteria

* Contraindicated for MRI * Pregnant * Age \<25 yrs

Design outcomes

Primary

Measure	Time frame
Magnetic Resonance Imaging (MRI) Viability: Comparison of Myocardial Viability by Positron Emission Tomography and MRI	time of initial scans

Secondary

Measure	Time frame
Compare size of regions of viable and non viable myocardium as % left ventricle by MRI vs. PET	at time of initial scans

Countries

United States

Outcome results